Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T70979 |
Sunepitron Free Base
|
||
Sunepitron Free Base is a combined 5-HT1A receptor agonist and α₂-adrenergic receptor antagonist. It was previously under development by Pfizer for the treatment of depression and anxiety. It made it to phase III clinical trials before being discontinued. | |||
T70981 |
CGS 22745
|
||
CGS 22745 is a selective orally active inhibitor of 5-lipoxygenase |